TikTok creator and ALS advocate Brooke Eby dies at 37

TikTok star and ALS advocate Brooke Eby has died at 37 after more than four years with the disease, the ALS Network said, as followers mourned the candid creator who refused to hide her decline.

NewsNation reported that the ALS Network announced Eby’s death Thursday, describing a young woman who turned a terminal diagnosis into a public record of grit, humor, and practical help for others facing the same illness.

Eby was 37. She had lived more than four years after doctors confirmed ALS, a progressive disease that steals muscle control and, in time, the ability to speak, swallow, and breathe. She first noticed symptoms about four years before that official diagnosis, then chose to put the fight on camera.

In 2022, only months after she learned what she was up against, she began posting as “Limpbroozkit” on TikTok and Instagram. Hundreds of thousands of people followed along. She did not sand down the hard parts. She called the diagnosis a “death sentence,” then kept showing up anyway.

That choice built a community far beyond entertainment clips. It also left a mark on families who know how fast life can change when serious illness or sudden loss arrives, a reality underscored in coverage of other recent cases, including when Worcester police identified a woman in a tragic murder-suicide.

Humor stayed her public weapon

Eby treated levity as strategy, not denial. In a 2023 interview with the “Today” show, she put it plainly: “Levity is my superpower.”

The ALS Network’s remembrance cast her the same way. The group said the ALS community is mourning an “extraordinary advocate, storyteller, community builder and friend.”

ALS Network President and CEO Sheri Strahl went further on what Eby changed.

“Brooke changed the way people see ALS, but she also changed the way people living with ALS find and support one another.”

Strahl added another line that captured the tone Eby set online.

“She brought humor into incredibly difficult moments, spoke with fearless honesty, and created connection where it was desperately needed.”

Those were not soft tributes layered on after the fact. They matched the record Eby built in public while the disease kept taking ground.

Her condition worsened in plain sight

Eby kept posting as her body failed in stages. In June last year, she said her breathing capacity had fallen sharply over the prior six months. She also told followers she had undergone a procedure to place a feeding tube in her stomach.

By January, she reported bulbar symptoms, trouble swallowing, speech changes, and more saliva. Speaking took longer. Significant slurring had not fully taken over yet.

Last month, in a TikTok update, she said her ability to speak had deteriorated rapidly. The arc was blunt and chronological: less air, less food by mouth, then a voice slipping away, all shared with the same audience that had met her years earlier.

High-profile deaths often force institutions and audiences to confront what was ignored until too late, a pattern also examined after the killing of Charlie Kirk and the security failures around it. Eby’s case was different in cause, yet similar in one respect, people were watching in real time as the outcome approached.

ALStogether turned following into practical help

Eby did not stop at storytelling. She founded ALStogether, a nonprofit built as a resource hub for people living with ALS. The project connected patients with experts, caregivers, health care providers, organizations, and others carrying the same diagnosis.

That is the part of her legacy that outlasts any single viral clip. Terminal illness strips people of control. A clear directory of help, built by someone living inside the same fight, is concrete service, not branding.

She documented the disease without waiting for permission from institutions or gatekeepers. She used open platforms, plain language, and steady updates. In an information culture that often filters hard medical realities, she put the progression where ordinary people could see it.

The ALS Network’s announcement closed a public journey that began with symptoms years before diagnosis, moved through a 2022 decision to post through the decline, and ended this week with an industry and patient community counting the loss of a 37-year-old advocate.

Eby showed that personal courage still matters when systems move slow and a diagnosis offers no bargain, honesty, humor, and useful work beat silence every time.